相关实验视频
Updated: Jan 18, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.2K
初级阿尔多斯特龙主义中的人工智能:当前的成就和未来的挑战
Yisi Xu1, Benjin Liu1, Xuqi Huang1
1Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Frontiers in molecular biosciences
|September 8, 2025
概括
人工智能 (AI) 增强了原发性阿尔多斯顿主义 (PA) 的诊断和治疗. 机器学习提高了查效率和诊断准确度,有助于个性化治疗和药物发现,尽管临床实施面临挑战.
科学领域:
- 内分泌学 在内分泌学.
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 原发性阿尔多斯特隆症 (PA) 的诊断和治疗是复杂的.
- 人工智能 (AI) 的进步为管理PA提供了新的工具.
- 目前对PA的诊断和治疗策略可以得到改进.
研究的目的:
- 审查人工智能对PA诊断和治疗的影响.
- 突出AI在查,诊断,亚型分类和治疗中的作用.
- 确定人工智能在PA管理中的挑战和未来方向.
主要方法:
- 关于人工智能应用在PA领域的最新文献的综述.
- 对PA查和诊断的机器学习模型的分析.
- 评估用于PA亚型分类和治疗预测的AI算法.
主要成果:
- 人工智能提高了PA查效率和诊断特异性.
- 人工智能算法使用各种数据准确地分类PA亚型.
- 预测模型指导个性化PA治疗,帮助药物发现.
- 挑战包括有限的数据,模型可解释性和现实世界的验证.
结论:
- 人工智能显示出极大的潜力,可以彻底改变PA的诊断和治疗.
- 进一步的研究需要更大的数据集,可解释的模型和多中心验证.
- 未来的努力应该集中在将AI整合到PA管理的临床途径中.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
943
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
943
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.4K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.5K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K

